A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
Background: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/1/91 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832587378466750464 |
---|---|
author | Mengyuan Liu Yixuan Liu Shaohui Song Qiurong Qiao Jing Liu Yun Xie Jian Zhou Guoyang Liao |
author_facet | Mengyuan Liu Yixuan Liu Shaohui Song Qiurong Qiao Jing Liu Yun Xie Jian Zhou Guoyang Liao |
author_sort | Mengyuan Liu |
collection | DOAJ |
description | Background: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our previous studies have demonstrated that an IAV NA mRNA vaccine can induce Th1-type immune responses in mice. This research examined the immune responses elicited by an mRNA vaccine targeting both HA and NA antigens in murine models. Methods: In this study, we used two dual-antigen immunization strategies: single-site immunization with an IAV HA+NA mRNA vaccine and multi-site immunization with an IAV HA mRNA vaccine and IAV NA mRNA vaccine. Hemagglutination-inhibiting antibody titer and neutralizing antibody titer in the sera of immunized mice were evaluated, and a viral challenge experiment was conducted. Additionally, the immune responses elicited by the two immunization strategies were characterized using flow cytometry and ELISA. Comparative analyses were performed with mice immunized individually with the IAV HA mRNA vaccine, IAV NA mRNA vaccine, and inactivated vaccine. Results: The results showed that by using a multi-site immunization strategy, mice were able to generate higher levels of hemagglutination-inhibiting and neutralizing antibodies, and were protected in a viral challenge experiment. Moreover, the multi-site regimen also promoted the generation of cytotoxic T cells and maintained a balanced Th1/Th2 immune response. Conclusions: Using mRNA vaccine based on a HA and NA antigen with multi-site immunization strategy can induce higher levels of hemagglutination-inhibiting and neutralizing antibodies, and multi-type immune responses in mice, providing new theoretical and experimental support for advancing upcoming influenza vaccines. |
format | Article |
id | doaj-art-a9f1790e9c9a455c833f6b5a1454b88d |
institution | Kabale University |
issn | 2076-393X |
language | English |
publishDate | 2025-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj-art-a9f1790e9c9a455c833f6b5a1454b88d2025-01-24T13:51:54ZengMDPI AGVaccines2076-393X2025-01-011319110.3390/vaccines13010091A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase AntigenMengyuan Liu0Yixuan Liu1Shaohui Song2Qiurong Qiao3Jing Liu4Yun Xie5Jian Zhou6Guoyang Liao7Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaKunming Medical University, Kunming 650500, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, ChinaBackground: The Influenza A virus (IAV), a pathogen affecting the respiratory system, represents a major risk to public health worldwide. Immunization remains the foremost strategy to control the transmission of IAV. The virus has two primary antigens: hemagglutinin (HA) and neuraminidase (NA). Our previous studies have demonstrated that an IAV NA mRNA vaccine can induce Th1-type immune responses in mice. This research examined the immune responses elicited by an mRNA vaccine targeting both HA and NA antigens in murine models. Methods: In this study, we used two dual-antigen immunization strategies: single-site immunization with an IAV HA+NA mRNA vaccine and multi-site immunization with an IAV HA mRNA vaccine and IAV NA mRNA vaccine. Hemagglutination-inhibiting antibody titer and neutralizing antibody titer in the sera of immunized mice were evaluated, and a viral challenge experiment was conducted. Additionally, the immune responses elicited by the two immunization strategies were characterized using flow cytometry and ELISA. Comparative analyses were performed with mice immunized individually with the IAV HA mRNA vaccine, IAV NA mRNA vaccine, and inactivated vaccine. Results: The results showed that by using a multi-site immunization strategy, mice were able to generate higher levels of hemagglutination-inhibiting and neutralizing antibodies, and were protected in a viral challenge experiment. Moreover, the multi-site regimen also promoted the generation of cytotoxic T cells and maintained a balanced Th1/Th2 immune response. Conclusions: Using mRNA vaccine based on a HA and NA antigen with multi-site immunization strategy can induce higher levels of hemagglutination-inhibiting and neutralizing antibodies, and multi-type immune responses in mice, providing new theoretical and experimental support for advancing upcoming influenza vaccines.https://www.mdpi.com/2076-393X/13/1/91influenza A virusmRNA vaccinehemagglutininneuraminidaseTh1Th2 |
spellingShingle | Mengyuan Liu Yixuan Liu Shaohui Song Qiurong Qiao Jing Liu Yun Xie Jian Zhou Guoyang Liao A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen Vaccines influenza A virus mRNA vaccine hemagglutinin neuraminidase Th1 Th2 |
title | A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen |
title_full | A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen |
title_fullStr | A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen |
title_full_unstemmed | A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen |
title_short | A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen |
title_sort | study on the induction of multi type immune responses in mice via an mrna vaccine based on hemagglutinin and neuraminidase antigen |
topic | influenza A virus mRNA vaccine hemagglutinin neuraminidase Th1 Th2 |
url | https://www.mdpi.com/2076-393X/13/1/91 |
work_keys_str_mv | AT mengyuanliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT yixuanliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT shaohuisong astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT qiurongqiao astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT jingliu astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT yunxie astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT jianzhou astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT guoyangliao astudyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT mengyuanliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT yixuanliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT shaohuisong studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT qiurongqiao studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT jingliu studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT yunxie studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT jianzhou studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen AT guoyangliao studyontheinductionofmultitypeimmuneresponsesinmiceviaanmrnavaccinebasedonhemagglutininandneuraminidaseantigen |